Skip to main content

The Triad of Estrogen, Estrogen Receptors, and Colon Cancer

  • Chapter
  • First Online:
Colon Cancer Diagnosis and Therapy Vol. 3

Abstract

Colon cancer is one of the common malignancies in the developed world irrespective of the sexes. The incidence of colon cancer is increasing leaps and bounds in the developing world also during the past few decades. Several risk factors including diet, environmental triggers, sedentary life style, and genetic susceptibility are known to predispose an individual for the development of colon cancer. Sex hormone estrogen plays a major role in various metabolic processes in the body, and deficiency in the levels of estrogen is reported to be a primary causative factor in the pathogenesis of many diseases including postmenopausal osteoporosis, cardiovascular disease, immune dysfunction, and many others. On the contrary, estrogens are also proven to exert a proproliferative effect in the reproductive organs, thereby establishing their role in the development of breast and endometrial cancers. Interestingly, hormone replacement therapy with estrogen is proven to reduce the risk of colorectal cancer (CRC) in postmenopausal women. Estrogen exerts its action by binding with nuclear receptors ERα and ERβ and also through binding with the membrane bound G-protein coupled estrogen receptor (GPER). Recent research has proven that the distribution of nuclear estrogen receptors alpha and beta in different organs and the preferential binding of estrogen to either of these receptors might be instrumental in determining the crucial switch between procarcinogenic and anticarcinogenic effects of estrogen. Reduced expression of the nuclear estrogen receptor beta in the colon is reported to enhance the risk of an individual for the development of CRC. This implicates the usefulness of estrogen receptor β expression as a reliable prognostic and diagnostic marker for CRC. In short, clinical endocrine therapies based on the estrogen-regulated expression of estrogen receptors, development of tissue selective estrogen receptor modulators, and phytoestrogen-based diets can all play a pivotal role in the prevention and therapy of colon cancer in the future. This chapter discusses the influence of estrogen and its constituent receptors in the development of colon cancers and as to how these can be exploited in the diagnosis, to monitor prognosis and to plan therapeutic regimes for the management of malignancies of the colon.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CIMP:

CpG island methylator phynotype

CIN:

Chromosomal instability

CRC:

colorectal cancer

ER:

Estrogen receptor

ERE:

Estrogen responsive elements

FPA:

Familial adenomatous polyposis

GPER:

G-protein coupled estrogen receptor

HNPCC:

Hereditary nonpolyposis colorectal cancer

SERD:

Selective estrogen receptor degrader

SERM:

Selective estrogen receptor modulator

References

  • Afrin, S., Giampieri, F., Gasparrini, M., Forbes-Hernández, T. Y., et al. (2020). Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnology Advances, 38, 107322.

    Article  CAS  PubMed  Google Scholar 

  • Alexander, D. D., Cushing, C. A., LowekaSceurman, B., & Roberts, M. A. (2009). Meta-analysis of animal fat or animal protein intake and colorectal cancer. The American Journal of Clinical Nutrition, 89, 1402–1409.

    Article  CAS  PubMed  Google Scholar 

  • Amersi, F., Agustin, M., & Ko, C. Y. (2005). Colorectal cancer: Epidemiology, risk factors, and health services. Clinics in Colon and Rectal Surgery, 18(3), 133–140.

    Article  PubMed  PubMed Central  Google Scholar 

  • Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A. A., Black, H., et al. (2004). Effects of conjugated equine estrogen in postmenopausal women, with hysterectomy: The Women’s Health Initiative randomized controlled trial. JAMA, 291(14), 1701–1712.

    Article  CAS  PubMed  Google Scholar 

  • André, T., & Gramont, A. (2004). An overview of adjuvant systemic chemotherapy for colon cancer. Clinical Colorectal Cancer, 4(1), S22–S28.

    Article  PubMed  Google Scholar 

  • Bain, D. L., Heneghan, A. F., Connaghan-Jones, K. D., et al. (2007). Nuclear receptor structure: Implications for function. Annual Review of Physiology, 69, 201–220.

    Article  CAS  PubMed  Google Scholar 

  • Bassottia, G., & Battagliab, E. (2015). Physiology of the colon. Coloproctology. https://doi.org/10.1007/978-3-319-10154-5_7-1

  • Bengtsson, A. K., Ryan, E. J., Giordano, D., Magaletti, D. M., & Clark, E. A. (2004). 17 beta estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cell. Blood, 2(104), 1404–1410.

    Article  CAS  Google Scholar 

  • Birkhauser, M. (1996). Treatment of pain in estrogen deficiency. Archives of Gynecology and Obstetrics, 259(Suppl 1), S74–S79.

    PubMed  Google Scholar 

  • Bjornstrom, L., & Sjoberg, M. (2005). Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Molecular Endocrinology, 19, 833–842.

    Article  PubMed  CAS  Google Scholar 

  • Bottner, M., Thelen, P., & Jarry, H. (2014). Estrogen receptor beta: Tissue distribution and the still largely enigmatic physiological function. The Journal of Steroid Biochemistry and Molecular Biology, 139, 245–251.

    Article  CAS  PubMed  Google Scholar 

  • Burns, K. A., & Korach, K. S. (2012). Estrogen receptors and human disease: An update. Archives of Toxicology, 86, 1491–1504.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bustos, V., Nolan, A. M., Nijhuis, A., Harvey, H., Parker, A., Poulsom, R., et al. (2017). GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget, 8, 84258–84275.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bye, W. A., Nguyen, T. M., Parker, C. E., et al. (2017). Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database of Systematic Reviews, 9, CD000279.

    Google Scholar 

  • Card, J. W., & Zeldin, D. C. (2009). Hormonal influences on lung function and response to environmental agents: Lessons from animal models of respiratory disease. Proceedings of the American Thoracic Society, 6, 588–595.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Carothers, A. M., Hughes, S. A., Ortega, D., & Bertagnoli, M. M. (2002). 2-Methoxyestradiol induces p53 associated apoptosis of colorectal cancer cells. Cancer Letters, 187(1–2), 77–86.

    Article  CAS  PubMed  Google Scholar 

  • Carreau, S., de Vienne, C., & Galeraud-Denis, I. (2008). Aromatase and estrogens in man reproduction: A review and latest advances. Adv Med Sci, 53, 139–144.

    Article  CAS  PubMed  Google Scholar 

  • Casals-Casas, C., & Desvergne, B. (2011). Endocrine disruptors: From endocrine to metabolic disruption. Annual Review of Physiology, 73, 135–162.

    Article  CAS  PubMed  Google Scholar 

  • Chang, E. C., Frasor, J., Komm, B., et al. (2006). Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology, 147, 4831–4842.

    Article  CAS  PubMed  Google Scholar 

  • Chlebowski, R. T., Wactawski-Wende, J., Ritenbaugh, C., Hubbell, A. F., Ascensao, J., Rodabough, R. J., et al. (2004). Estrogen plus progestin and colorectal cancer in postmenopausal women. The New England Journal of Medicine, 350(10), 991–1004.

    Article  CAS  PubMed  Google Scholar 

  • Cianchi, F., Trallori, G., Mallardi, B., et al. (2015). Survival after laparoscopic and open surgery for colon cancer: A comparative, single-institution study. BMC Surgery, 15, 33.

    Article  PubMed  PubMed Central  Google Scholar 

  • Clendenen, T. V., Koenig, K. I., Shore, R. E., Levitz, M., Arslan, A. A., & Zeleniuch-Jacquotte, A. (2009). Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention, 18(1), 275–281.

    Article  CAS  Google Scholar 

  • Cui, J., Shen, Y., & Li, R. (2013). Estrogen synthesis and signaling pathways during aging: From periphery to brain. Trends in Molecular Medicine, 19(3), 197–209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cvoro, A., Tatomer, D., Tee, M.-K., Zogovic, T., et al. (2008). Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes. Journal of Immunology, 180, 630–636.

    Article  CAS  Google Scholar 

  • Deyhle, P., Largiader, F., Jenny, S., et al. (1973). A method for endoscopic electroresection of sessile colonic polyps. Endoscopy, 5, 38–40.

    Article  Google Scholar 

  • Dray, X., Ruault, M. B., Sapinhi, D., Bouvier, A. M. B., & Faivre, J. (2003). Influence of dietary factors on colorectal cancer survival. Gut, 52(6), 868–873.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Edvardsson, K., Strom, A., Jonsson, P., Gustafsson, J., & Williams, C. (2011). Estrogen receptor β induces anti-inflammatory and antitumorigenic networks in colon cancer cells. Molecular Endocrinology, 25, 969–979.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ewing, I., Hurley, J. J., Josephides, E., & Millar, A. (2014). The molecular genetics of colorectal cancer. Frontline Gastroenterology, 5(1), 26–30.

    Article  CAS  PubMed  Google Scholar 

  • Fearon, E. R., & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 451–457.

    Google Scholar 

  • Fernandez, F., La Vecchia, C., Balducci, A., et al. (2001). Oral contraceptives and colorectal cancer risk : A meta analysis. British Journal of Cancer, 84(5), 722–727.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Frasor, J., Danes, J. M., Komm, B., et al. (2003). Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology, 144, 4562–4574.

    Article  CAS  PubMed  Google Scholar 

  • Gill, S., Thomas, R. R., & Goldberg, R. M. (2003). Review article: Colorectal cancer chemotherapy. Alimentary Pharmacology & Therapeutics, 18(7), 683–692.

    Article  CAS  Google Scholar 

  • Gilligan, L. C., Gondal, A., Tang, V., Hussain, M. T., Arvaniti, A., Hewitt, A. M., & Foster, P. A. (2017). Estronesulfate transport and steroid sulfatase activity in colorectal cancer: Implications for hormone replacement therapy. Frontiers in Pharmacology, 8, 103.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Granados-Romero, J. J., Valderrama-Treviño, A. I., Contreras-Flores, E. H., et al. (2017). Colorectal cancer: A review. International Journal of Research in Medical Sciences, 5(11), 4667–4676.

    Article  Google Scholar 

  • Gronemeyer, H., Gustafsson, J. A., & Laudet, V. (2004). Principles for modulation of the nuclear receptor superfamily. Nature Reviews Drug Discovery, 3, 950–964.

    Article  CAS  PubMed  Google Scholar 

  • Gruber, C. J., Tschugguel, W., Schneeberger, C., et al. (2002). Production and actions of estrogens. The New England Journal of Medicine, 346, 340–352.

    Article  CAS  PubMed  Google Scholar 

  • Guan, X., Zhao, Z., Yang, M., et al. (2017). Whether partial colectomy is oncologically safe for patients with transverse colon cancer: A large population-based study. Oncotarget, 8(54), 93236–93244.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gunter, M. J., Hoover, D. R., Yu, H., TE Wassertheil-Smoller, R., Manson, J. E., et al. (2008). Insulin, insulin-like growth factor-I, endogenous estradiol and risk of colorectal cancer in postmenopausal women. Cancer Research, 68(1), 329–337.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haas, M. J., Raheja, P., Jaimungal, S., et al. (2012). Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cells. Free Radical Biology & Medicine, 52, 2161–2167.

    Article  CAS  Google Scholar 

  • Haggar, F. A., & Boushey, R. P. (2009). Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clinics in Colon and Rectal Surgery, 22(4), 191–197.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hamilton, E. P., Patel, M. R., Armstrong, A. C., et al. (2018). A first-in-human study of the new Oral selective Estrogen receptor degrader AZD9496 for ER(+)/HER2(−) advance breast Cancer. Clinical Cancer Research, 24, 3510–3518.

    Article  CAS  PubMed  Google Scholar 

  • Harshman, M. R. (2007). Diet and colorectal cancer. Canadian Family Physician, 53(11), 1913–1920.

    Google Scholar 

  • Heldring, N., Pike, A., Andersson, S., et al. (2007). Estrogen receptors: How do they signal and what are their targets. Physiological Reviews, 87, 905–931.

    Article  CAS  PubMed  Google Scholar 

  • Henrikson, N. B., Webber, E. M., Katrina, A., et al. (2015). Family history and the natural history of colorectal cancer: Systematic review. Genetics in Medicine, 17(9), 702–712.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hsu, H. H., Cheng, S. F., Wu, C. C., et al. (2006). Apoptotic effects of overexpressed estrogen receptor beta on LOVO colon cancer cell is mediated by p 53 signallings in a ligand-dependent manner. The Chinese Journal of Physiology, 49(2), 110–116.

    CAS  PubMed  Google Scholar 

  • Huang, P., Chandra, V., & Rastinejad, F. (2010). Structural overview of the nuclear receptor superfamily: Insights into physiology and therapeutics. Annual Review of Physiology, 72, 247–272.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., et al. (1992). Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proceedings of the National Academy of Sciences of the United States of America, 89, 4658–4662.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Inoue, T., Miki, Y., Abe, K., et al. (2012). Sex steroid synthesis in human skin in situ: The roles of aromatase and steroidogenic acute regulatory protein in the homeostasis of human skin. Molecular and Cellular Endocrinology, 362, 19–28.

    Article  CAS  PubMed  Google Scholar 

  • Issa, J. P. (2008). Colon cancer: Its CIN or CIMP. Clinical Cancer Research, 14(19), 5939–5940.

    Article  PubMed  Google Scholar 

  • Jensen, E. V., Jacobson, H. E., Flesher, J. W., et al. (1966). Estrogen receptors in target tissues. In T. Nakao, G. Pincus, & J. Tait (Eds.), Steroid dynamics (pp. 133–157). New York, NY: Academic Press.

    Chapter  Google Scholar 

  • Jia, M., Dahlman-Wright, K., & Gustafsson, J. A. (2015). Estrogen receptor alpha and beta in health and disease. Best Practice and Research: Clinical Endocrinology and Metabolism, 29, 557–568.

    Article  CAS  PubMed  Google Scholar 

  • Jin, P., Lu, X. J., Sheng, J. Q., Fu, L., et al. (2010). Estrogen stimulates the expression of mismatch repair genes MLH 1 in colonic epithelial cells. Cancer Prevention Research (Philadelphia, PA), 3(8), 910–916.

    Article  CAS  Google Scholar 

  • Jonsson, P., Katchy, A., & Williams, C. (2014). Support of a bi-faceted role of estrogen receptor beta (ERbeta) in ERalpha-positive breast cancer cells. Endocrine-Related Cancer, 21, 143–160.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jordan, V. C. (2001). Selective estrogen receptor modulation: A personal perspective. Cancer Research, 61, 5683–5687.

    CAS  PubMed  Google Scholar 

  • Jung, J. (2019). G protein coupled estrogen receptor in cancer progression. Toxicological Research, 35, 209–214.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kasprzak, A., & Adamek, A. (2019). Insulin-like growth factor 2 (IGF2) signaling in colorectal cancer-from basic research to potential clinical applications. International Journal of Molecular Sciences, 20(19), 4915.

    Article  CAS  PubMed Central  Google Scholar 

  • Kato, S., Endoh, H., Masuhiro, Y., et al. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science, 270, 1491–1494.

    Article  CAS  PubMed  Google Scholar 

  • Kim, E. R., & Chang, D. K. (2014). Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis. World Journal of Gastroenterology, 20(29), 9872–9881.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Klotz, D. M., Hewitt, S. C., Ciana, P., Raviscioni, M., et al. (2002). Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)- induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. The Journal of Biological Chemistry, 277, 8531–8537.

    Article  CAS  PubMed  Google Scholar 

  • Kotov, A., Falany, J. L., Wang, J., et al. (1999). Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. The Journal of Steroid Biochemistry and Molecular Biology, 68, 137–144.

    Article  CAS  PubMed  Google Scholar 

  • Koushik, A., Hunter, D. J., Spiegelman, D., et al. (2007). Fruits, vegetables and colon cancer risk in a pooled analysis of 14 cohort studies. Journal of the National Cancer Institute, 99, 1471–1483.

    Article  PubMed  Google Scholar 

  • Kovats, S., & Carreas, E. (2008). Regulation of dendritic cell differentiation and function by estrogen receptor ligands. Cellular Immunology, 252, 81–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuiper, G. G., Enmark, E., Pelto-Huikko, M., et al. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences of the United States of America, 93, 5925–5930.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuipers, E. J., Grady, W. M., Lieberman, D., et al. (2015). Colorectal cancer. Nature Reviews. Disease Primers, 1, 15065.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lechner, D., Kállay, E., & Cross, H. S. (2005). Phytoestrogens and colorectal cancer prevention. Vitamins & Hormones, 70, 169–198.

    Article  CAS  Google Scholar 

  • Leung, Y. K., Mak, P., Hassan, S., et al. (2006). Estrogen receptor (ER)-beta isoforms: A key to understanding ER-beta signaling. Proceedings of the National Academy of Sciences of the United States of America, 103, 13162–13167.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Levin, E. R. (2009). Plasma membrane estrogen receptors. Trends in Endocrinology and Metabolism, 20, 477–482.

    Article  CAS  PubMed  Google Scholar 

  • Liao, T. L., Tzeng, C. R., Yu, C. L., et al. (2015). Estrogen receptor-beta in mitochondria: Implications for mitochondrial bioenergetics and tumorigenesis. Annals of the New York Academy of Sciences, 1350, 52–60.

    Article  CAS  PubMed  Google Scholar 

  • Lin, J. H., & Giovannucci, E. (2010). Sex hormones and colorectal cancer: What have we learned so far? Journal of the National Cancer Institute, 102(23), 1746–1747.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lombardi, G., Zarrilli, S., Colao, A., et al. (2001). Estrogens and health in males. Molecular and Cellular Endocrinology, 178, 51–55.

    Article  CAS  PubMed  Google Scholar 

  • Lynch, P. M. (2017). History of hereditary non polyposis colorectal cancer or “Lynch syndrome”. Revista Médica Clínica Las Condes, 28(4), 500–511.

    Article  Google Scholar 

  • Maggiolini, M., Vivacqua, A., Fasanella, G., et al. (2004). The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. The Journal of Biological Chemistry, 279, 27008–27016.

    Article  CAS  PubMed  Google Scholar 

  • Martin, M. B., Franke, T. F., & Stoica, G. E. (2000). A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology, 141, 4503–4511.

    Article  CAS  PubMed  Google Scholar 

  • Mastalier, B., Tihon, C., Ghiţă, B., et al. (2012). Surgical treatment of colon cancer: Colentina surgical clinic experience. Journal of Medicine and Life, 5(3), 348–353.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The role of estrogens in control of energy balance and glucose homeostasis. Endocrine Reviews, 34(3), 309–338.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mazaira, G. I., Zgajnar, N. R., Lotufo, C. M., et al. (2018). The nuclear receptor field: A historical overview and future challenges. Nuclear Receptor Research, 5, 101320.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Menon, R., Watson, S. E., Thomas, L. N., Alfred, C. D., et al. (2013). Diet complexity and estrogen receptor β status affect the composition of the murine intestinal microbiota. Applied and Environmental Microbiology, 79, 5763.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Murphy, N., Xu, L., Zervoudakis, A., TE Xue, X., et al. (2017). Reproductive and menstrual factors and colorectal cancer incidence in the Womens Health Initiative Observational Study. British Journal of Cancer, 116, 117–125.

    Article  PubMed  Google Scholar 

  • Nardone, A., Weir, H., Delpuech, O., et al. (2019). The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. British Journal of Cancer, 120, 331–339.

    Article  CAS  PubMed  Google Scholar 

  • Neubig, R. R., Spedding, M., Kenakin, T., et al. (2003). International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacological Reviews, 55, 597–606.

    Article  CAS  PubMed  Google Scholar 

  • Nilsson, S., & Gustafsson, J. A. (2011). Estrogen receptors: Therapies targeted to receptor subtypes. Clinical Pharmacology and Therapeutics, 89, 44–55.

    Article  CAS  PubMed  Google Scholar 

  • Nilsson, S., Koehler, K. F., & Gustafsson, J. A. (2011). Development of subtype-selective oestrogen receptor-based therapeutics. Nature Reviews Drug Discovery, 10, 778–792.

    Article  CAS  PubMed  Google Scholar 

  • Pancione, M., Remo, A., & Colantuoni, V. (2012). Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Pathology Research International, 2012, 509348.

    Article  PubMed  PubMed Central  Google Scholar 

  • Paterni, I., Granchi, C., Katzenellenbogen, J. A., et al. (2014). Estrogen receptors alpha (ERalpha) and beta (ERbeta): Subtype-selective ligands and clinical potential. Steroids, 90, 13–29.

    Article  CAS  PubMed  Google Scholar 

  • Patrone, C., Ma, Z. Q., Pollio, G., et al. (1996). Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Molecular Endocrinology, 10, 499–507.

    CAS  PubMed  Google Scholar 

  • Pedram, A., Razandi, M., & Levin, E. R. (2006). Nature of functional estrogen receptors at the plasma membrane. Molecular Endocrinology, 20, 1996–2009.

    Article  CAS  PubMed  Google Scholar 

  • Pietras, R. J., & Marquez-Garban, D. C. (2007). Membrane-associated estrogen receptor signaling pathways in human cancers. Clinical Cancer Research, 13, 4672–4676.

    Article  CAS  PubMed  Google Scholar 

  • Pinheiro, M., Ahlquist, T., Danielsen, S. A., et al. (2010). Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin. BMC Cancer, 10, 587.

    Article  PubMed  PubMed Central  Google Scholar 

  • Potter, J. D. (1996). Nutrition and colorectal cancer. Cancer Causes and Control, 7, 127–146.

    Article  CAS  PubMed  Google Scholar 

  • Power, R. F., Mani, S. K., Codina, J., et al. (1991). Dopaminergic and ligand-independent activation of steroid hormone receptors. Science, 254, 1636–1639.

    Article  CAS  PubMed  Google Scholar 

  • Prossnitz, E. R., & Barton, M. (2011). The G-protein-coupled estrogen receptor GPER in health and disease. Nature Reviews Endocrinology, 7, 715–726.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rawla, P., Sunkara, T., & Barsouk. (2019). Epidemiology of colorectal cancer:Incidence, mortality, survival, and risk factors. Przegla̜d Gastroenterologiczny, 14(2), 89–103.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Rawluszko-Wieczorek, A. A., Marczak, L., et al. (2017). Significance of intratissue estrogen concentration coupled with estrogen receptor levels in colorectal cancer prognosis. Oncotarget, 8(70), 115546–115560.

    Article  PubMed  PubMed Central  Google Scholar 

  • Revankar, C. M., Cimino, D. F., Sklar, L. A., et al. (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science (New York, NY), 307, 1625–1630.

    Article  CAS  Google Scholar 

  • Richardson, T. E., Yu, A. E., Wen, Y., et al. (2012). Estrogen prevents oxidative damage to the mitochondria in Friedreich’s ataxia skin fibroblasts. PLoS One, 7, e34600.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Riihimäki, M., Hemminki, A., Sundquist, J., & Hemminki, K. (2016). Patterns of metastasis in colon and rectal cancer. Scientific Reports, 6, 29765.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rosenbaum, D. M., Rasmussen, S. G., & Kobilka, B. K. (2009). The structure and function of G-protein-coupled receptors. Nature, 459, 356–363.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sameer, A. S. (2013). Colorectal cancer: Molecular mutations and polymorphisms. Frontiers in Oncology, 3, 114.

    Article  PubMed  PubMed Central  Google Scholar 

  • Santen, R. J., Brodie, H., Simpson, E. R., et al. (2009). History of aromatase: Saga of an important biological mediator and therapeutic target. Endocrine Reviews, 30, 343–375.

    Article  CAS  PubMed  Google Scholar 

  • Santolla, M. F., Lappano, R., De Marco, P., Pupo, M., Vivacquo, A., Sisci, D., et al. (2012). G-Protein Coupled Estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17 beta estradiol in cancer cells and cancer associated fibroblasts. Journal of Biological Chemistry, 287, 43234–43245.

    Article  CAS  Google Scholar 

  • Sarkar, S., Horn, G., & Moulton, K. (2013). Cancer development, progression, and therapy: An epigenetic overview. International Journal of Molecular Sciences, 14(10), 21087–21113.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Schreihofer, D. A., Resnick, E. M., Lin, V. Y., et al. (2001). Ligand-independent activation of pituitary ER: Dependence on PKA stimulated pathways. Endocrinology, 142, 3361–3368.

    Article  CAS  PubMed  Google Scholar 

  • Sladek, F. M. (2003). Nuclear receptors as drug targets: New developments in coregulators, orphan receptors and major therapeutic areas. Expert Opinion on Therapeutic Targets, 7, 679–684.

    Article  CAS  PubMed  Google Scholar 

  • Slattery, M. I., Sweeny, C., Murtaugh, M., Ma, M., Wolff, R. K., Potter, J. D., et al. (2005). Associations between ER alpha, ER beta and AR genotypes and colon and rectal cancer. Cancer Epidemiology, Biomarkers & Prevention, 14(12), 2936–2942.

    Article  CAS  Google Scholar 

  • Tanaka, T. (2009). Colorectal carcinogenesis: Review of human and experimental animal studies. Journal of Carcinogenesis, 8, 5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tariq, K., & Ghias, K. (2016). Colorectal cancer carcinogenesis: A review of mechanisms. Cancer Biology & Medicine, 13(1), 120–135.

    Article  CAS  Google Scholar 

  • Terzic, J., Grivennikov, S., Karin, E., & Karin, M. (2010). Inflammation and colon cancer. Review Gastroenterology, 138(6), 2101–2114.e5.

    Article  CAS  PubMed  Google Scholar 

  • Thompson, C. A., Forest, A. D., & Battle, M. A. (2018). Patterning the gastrointestinal epithelium to confer regional-specific functions. Developmental Biology, 435(2), 97–108.

    Article  CAS  PubMed  Google Scholar 

  • Topi, G., Ehmstrom, R., Jirstrom, K., Palmquist, J., Lydrup, M., & Sjolander, A. (2017). Association of the estrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer. European Journal of Cancer, 83, 279–289.

    Article  CAS  PubMed  Google Scholar 

  • Umar, S. (2010). Intestinal stem cells. Current Gastroenterology Reports, 12(5), 340–348.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wettschureck, N., & Offermanns, S. (2005). Mammalian G proteins and their cell type specific functions. Physiological Reviews, 85, 1159–1204.

    Article  CAS  PubMed  Google Scholar 

  • Xie, Y. H., Chen, Y. X., & Fang, J. Y. (2020). Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy, 5(1), 22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yager, J. D., & Chen, J. Q. (2007). Mitochondrial estrogen receptors--new insights into specific functions. Trends in Endocrinology and Metabolism, 18, 89–91.

    Article  CAS  PubMed  Google Scholar 

  • Ye, S., Cheng, Y., Zhang, L., Wang, X., et al. (2019). Prognostic value of estrogen receptor αand progesterone receptor in curatively resected colorectal cancer: A retrospective analysis with independent validations. BMC Cancer, 19, 933.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yue, W., Wang, J. P., Li, Y., et al. (2010). Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. International Journal of Cancer, 127, 1748–1757.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zauber, A. G., Winawer, S. J., O'Brien, M. J., et al. (2012). Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. The New England Journal of Medicine, 366(8), 687–696.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu, G., Huang, Y., Wu, C., Wei, D., & Shi, Y. (2016). Activation of G Protein-Coupled Estrogen receptor inhibits the migration of human non small cell lung cancer cells via IKK beta/NF-kappa B signals. DNA and Cell Biology, 35, 434–442.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank the University Grants Commission (UGC), Government of India, for the financial assistance provided to the Department of Microbiology and Biotechnology, Bangalore University, Bangalore, in the form of Special Assistance Programme (SAP)-DRS II which provided support for extensive literature survey and procurement of stationery material and to incur expenditure toward printing and photocopying charges for writing this chapter. Dr. SK acknowledges the financial assistance provided by UGC, GOI, in the form of postdoctoral fellowship (Dr. D.S. Kothari-PDF).

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sumalatha, K.R., Soumyakrishnan, S., Sreepriya, M. (2022). The Triad of Estrogen, Estrogen Receptors, and Colon Cancer. In: Shukla, D., Vishvakarma, N.K., Nagaraju, G.P. (eds) Colon Cancer Diagnosis and Therapy Vol. 3. Springer, Cham. https://doi.org/10.1007/978-3-030-72702-4_3

Download citation

Publish with us

Policies and ethics